Tejido linfático asociado a mucosas: Células presentadoras de antígenos / Mucose associated lymphoid tissue: Antigen presenting cells

Se estudiaron al microscopio electrónico biopsias de mucosas normales y patológicas (cavidad bucal y cuello uterino), con especial atención a los sistemas de defensa existentes en las células epiteliales (CE) y en las células dendríticas (CD). Las CE, cuando están activadas, muestran su capacidad de fagocitar y procesar antígenos con la finalidad de presentarlos luego a las CD; los elementos implicados en esta función son vesículas de micropinocitosis, cuerpos multivesiculares, lisosomas, fagosomas, vesículas recubiertas por clatrina, gránulos de contenido denso recubiertos por una unidad de membrana, gránulos en cuyo interior se aprecian láminas que simulan hojas de cebolla, microcuerpos y gránulos con actividad de fosfatasa ácida. Las CD que recién han ingresado al interior del epitelio son de baja densidad electrónica y poseen grandes prolongaciones citoplasmáticas, que luego se reducen de tamaño, a la vez que aumenta la densidad de su citoplasma. Muestran vesículas de micropinocitosis, algunas recubiertas por clatrina, lisosomas y corpúsculos de Birberk. En este momento son reconocidas como células de Langerhans. Tanto en las CE como en las CD existen abundantes “pliegues marginales o de superficie“ (surface folds), conteniendo numerosas vesículas de micropinocitosis. Entre la CE y la CD se establecen íntimos contactos a través de los cuales las primeras presentan los antígenos fagocitados y tratados a las CD donde son terminados de procesar y se unen a las moléculas del complejo principal de histocompatibilidad y/o a moléculas con función similar (CD1). Las CD migran a los ganglios linfáticos donde presentan los antígenos a los linfocitos T y empieza el proceso de activación de estos, que conduce a la defensa frente a las noxas que han ingresado al organismo. De esta manera tanto las CD como las CE son un lazo de unión entre los sistemas de defensa innata y la adquirida.

We studied samples of normal and abnormal human mucosae, including oral tissue and uterine cervix, using electron microscopy. Special attention was given to the functions and mechanisms of defense carried out by the epithelial (EC) and dendritic cells (DC). Activated epithelial cells posses the capacity to uptake and process antigens, in order to present them, subsequently, to the dendritic cells. The structures and elements of the cells intervening on this function are: micropinocytic vesicles, multivesicular bodies, lysosomes, phagosomes, clathrin-covered vesicles, dense granules covered by a unit membrane, granules with onion likes leaves, microbodies, and dense granules with acid phosphatase activity. When they first arrive within the epithelial layers, the DC are clear with long cytoplasmic projections, which later become short, and the density of their cytoplasm increases. They possess mycropinocytic vesicles, some clathrine-covered vesicles, lysososmes and Birbeck granules. At this moment, they are known as Langerhans cells. EC and DC present many surface folds rich in micropynocytic vesicles. Between EC and DC there are many contacts (close junctions or tight junctions), through which antigens, phagocitized and processed by the EC, are given to the DC. These cells join them to major histocompatibility complex molecules or to other molecules with similar functions (CD1). Then the Langerhans cells travel to the lymphatic node to activate T cells and continue the immunologic task. So, in this way, both the EC and the DC are a link between the natural and the acquired immunological mechanisms.

Morphometric analysis of dendritic cells from anal mucosa of HIV-positive patients and the relation to intraepithelial lesions and cancer seen at a tertiary health institution in Brazil / Análise morfométrica das células dendríticas da mucosa anal de pacientes HIV-positivos e relação com as lesões intraepiteliais e o câncer numa instituição de saúde terciária no Brasil

PURPOSE: To morphometrically quantify CD1a+ dentritic cells and DC-SIGN+ dendritic cells in HIV-positive patients with anal squamous intraepithelial neoplasia and to evaluate the effects of HIV infection, antiretroviral therapy and HPV infection on epithelial and subepithelial dendritic cells. METHODS: A prospective study was performed to morphometrically analyze the relative volume of the dendritic cells and the relationship between anal intraepithelial neoplasia and cancer in HIV-positive patients from the Tropical Medicine Foundation of Amazonas, Brazil. All patients were submitted to biopsies of anorectal mucosa to perform a classic histopathological and immunohistochemical analysis, employing antibodies against CD1a and DC-SIGN for the morphometric quantification of dendritic cells. RESULTS: HIV-negative patients displayed a CD1a DC density significantly higher than that of HIV-positives patients (3.75 versus 2.54) (p=0.018), and in patients with severe anal intraepithelial neoplasia had correlated between DC CD1a density with levels of CD4 + cells (p: 0.04) as well as the viral load of HIV-1 (p: 0.035). A not significant rise in the median density of CD1a+ DC was observed in the HIV positive/ HAART positive subgroup compared to the HIV positive/ HAART negative subgroup. The CD1a+ DC were also significantly increased in HIV-negative patients with anorectal condyloma (2.33 to 3.53; p=0.05), with an opposite effect in HIV-positive patients. CONCLUSIONS: Our data support an enhancement of the synergistic action caused by HIV-HPV co-infection on the anal epithelium, weakening the DC for its major role in immune surveillance. Notoriously in patients with severe anal intraepithelial neoplasia, the density of CD1a+ epithelial dendritic cells was influenced by the viral load of HIV-1. Our study describes for the first time the density of subepithelial DC-SIGN+ dendritic cells in patients with anal severe anal intraepithelial neoplasia and points to the possibility that a specific therapy for HIV induces the recovery of the density of epithelial DC.

OBJETIVO: Quantificar morfometricamente as células dendríticas DC CD1a+ e DC DC-SIGN+ em pacientes HIV positivos portadores de neoplasia escamosa intraepitelial anal e avaliar os efeitos da infecção pelo HIV, da terapia antirretroviral e da infecção pelo HPV sobre as células dendríticas epiteliais e subepiteliais. MÉTODOS: Um estudo prospectivo foi realizado para analisar morfometricamente o volume relativo das células dendríticas e as relações entre neoplasia intraepitelial anal e o câncer em pacientes HIV positivos da Fundação de Medicina Tropical do Amazonas, Brasil.Todos os pacientes foram submetidos a biópsia da mucosa retal para realizar uma análise clássica histopatológica e imunohistoquímica utilizando anticorpos contra anti-CD1a e anti-DC-SIGN, para a quantificação morfométrica das células dendríticas. RESULTADOS: Os pacientes HIV negativos apresentaram densidade das DC CD1a+ significativamente maior do que a dos pacientes HIV positivos (3,75 versus 2,54) (p:0,018), e os pacientes com severa apresentaram correlação das DC CD1a com os níveis de células TCD4(p:0,04) assim como a carga viral do HIV-1 (p:0,035). Observamos no subgrupo HIV-positivo/HAART positivo elevação não significativa na mediana da densidade das DC CD1a+ em relação ao grupo HIV-positivo/HAART negativo. As DC CD1a+ também se elevaram nos pacientes HIV negativo portadores de condiloma anorretal(2,33 para 3,53; p:0,05), com efeito inverso nos pacientes HIV positivos. CONCLUSÕES: Nossos dados confirmam a potencialização da ação sinérgica representada pela coinfecção HIV-HPV sobre o epitélio anal, fragilizando as DC em sua função primordial de vigilância imune. Notoriamente nos pacientes com neoplasia intraepithelial anal grave, a densidade das DC CD1a+ epiteliais sofreu influência da carga viral do HIV-1. Nosso estudo descreveu pela primeira vez a densidade das DC subepiteliais DC-SIGN+ em pacientes com neoplasia intraepithelial anal severa e apontamos para a possibilidade de que a terapia específica para o HIV induza a recuperação da densidade das DC epiteliais.

Helicobacter pylori vaccine: mucosal adjuvant & delivery systems.

Vaccination, especially mucosal vaccination, is considered to be effective in the management of Helicobacter pylori infections. However, most antigens alone cannot induce immune responses when administered mucosally and need to be co-administered with adjuvants or delivery systems. The current research on the mucosal adjuvant and delivery systems of vaccine against H. pylori, including advantages and disadvantages, mechanisms and applications is discussed in this review. Mutants of cholera toxin (CT) and the heat labile enterotoxin of Escherichia coli (LT), CpG oligodeoxynucleotides, biocompatible and biodegradable polymers, and live attenuated bacterial vectors may be promising adjuvant and delivery systems for H. pylori vaccine.

Locally produced mucosal IgG in chickens immunized with conventional vaccines for Newcastle disease virus

Newcastle disease virus (NDV) is the causative agent of an economically important disease, which affects all species of birds worldwide. Current vaccination programs for NDV include the use of either low-virulent live-virus vaccines or inactivated vaccines to induce protective immunity while producing minimal adverse effects in birds. In order to further characterize the immune response elicited by live virus and inactivated NDV conventional vaccines in chickens, we evaluated the presence of specific antibodies in different secretions and in tissue culture supernatants of immunized birds. To this end, we analyzed all the samples by ELISA, using an indirect assay set up in the laboratory. Specific anti-NDV IgG antibodies were detected in tracheal and cloacal swabs and tracheal and intestinal washes of immunized animals. We also found specific anti-NDV IgG antibodies in tracheal and intestinal tissue culture supernatants, indicating that the IgG found in swabs and washes was not transudated from serum or, at least, was not all transudated from serum. Knowledge about the mechanisms involved in the immune response of chickens to different NDV vaccines should increase our understanding of the mucosal response against the virus and, eventually, provide new useful information for the development and evaluation of synthetic vaccines.

Immunohistochemical evaluation of the inflammatory response in periodontal disease

In order to contribute to the knowledge of the pathogenesis of periodontal disease, an immunohistochemical analysis of the density of inflammatory mononucleated cells and the number of dendritic cells was performed using anti-CD4, anti-CD20, anti-CD25, anti-CD68 and anti-protein S-100 antibodies in 17 cases of chronic gingivitis (CG) and 25 of chronic periodontitis (CP). The CD4+ and CD68+ cells exhibited a diffuse distribution in the connective tissue. CD20+ cell distribution was predominantly in groups and the CD25+ cells exhibited a diffuse or focal distribution. The S-100+ cells were identified in the epithelium and the lamina propria, exhibiting distinct morphology and number. The statistical analysis showed no significant differences (p>0.05) between CG and CP regarding the density of the CD4+ and CD20+ cells and the number of S-100+ cells. However, significant differences (p<0.05) were found between the groups in the density of CD25+ and CD68+ cells . The density of macrophages was greater in CG and the level of cellular activation of the lymphocyte infiltrate was greater in CP. No differences were detected between the aforementioned conditions regarding the density of the T and B lymphocytes and to the number of the dendritic cells.

Com o objetivo de contribuir para um melhor entendimento na etiopatogenia da doença periodontal, um análise imuno-histoquímica da densidade das células inflamatórias mononucleares e da quantidade das células dendríticas foi realizada utilizando os anticorpos anti-CD4, anti-CD20, anti-CD25, anti-CD68 and anti-proteína S-100 em 17 casos de gengivite crônica (GC) e 25 casos de periodontite crônica (PC). As células CD4+ e CD68+ exibiram distribuição difusa no tecido conjuntivo, enquanto que a distribuição das células CD20+ foi predominantemente em grupos, e as CD25+ exibiram distribuição ora difusa ora focal. As células S-100+ foram identificadas no epitélio e na lamina própria, exibindo morfologia e números distintos. A análise estatística não demonstrou diferenças estatisticamente significativas em relação a densidade das células CD4+ e CD20+ e no número de células S-100+ entre os casos de CG e PC. Entretanto, houve diferenças em relação a densidade das células CD25+ e CD68+ entre os grupos (p<0,05). A densidade dos macrófagos foi maior em GC e o nível de ativação celular do infiltrado linfocítico foi maior em PC, não havendo diferenças em relação a densidade de linfócitos T e B, bem como no número de células dendríticas entre as condições anteriormente mencionadas.

Neutrophil transepithelial migration: role of toll-like receptors in mucosal inflammation

The symptomatic phases of many inflammatory diseases are characterized by migration of large numbers of neutrophils (PMN) across a polarized epithelium and accumulation within a lumen. For example, acute PMN influx is common in diseases of the gastrointestinal system (ulcerative colitis, Crohn's disease, bacterial enterocolitis, gastritis), hepatobiliary system (cholangitis, acute cholecystitis), respiratory tract (bronchial pneumonia, bronchitis, cystic fibrosis, bronchiectasis), and urinary tract (pyelonephritis, cystitis). Despite these observations, the molecular basis of leukocyte interactions with epithelial cells is incompletely understood. In vitro models of PMN transepithelial migration typically use N-formylated bacterial peptides such as fMLP in isolation to drive human PMNs across epithelial monolayers. However, other microbial products such as lipopolysaccharide (LPS) are major constituents of the intestinal lumen and have potent effects on the immune system. In the absence of LPS, we have shown that transepithelial migration requires sequential adhesive interactions between the PMN beta2 integrin CD11b/CD18 and JAM protein family members. Other epithelial ligands appear to be abundantly represented as fucosylated proteoglycans. Further studies indicate that the rate of PMN migration across mucosal surfaces can be regulated by the ubiquitously expressed transmembrane protein CD47 and microbial-derived factors, although many of the details remain unclear. Current data suggests that Toll-like receptors (TLR), which recognize specific pathogen-associated molecular patterns (PAMPs), are differentially expressed on both leukocytes and mucosal epithelial cells while serving to modulate leukocyte-epithelial interactions. Exposure of epithelial TLRs to microbial ligands has been shown to result in transcriptional upregulation of inflammatory mediators whereas ligation of leukocyte TLRs modulate specific antimicrobial responses. A better understanding of these events will hopefully provide new insights into the mechanisms of epithelial responses to microorganisms and ideas for therapies aimed at inhibiting the deleterious consequences of mucosal inflammation.

Expresión de células CD11b-positivas en mucosa rectal de conejos sensibilizados y desafiados con ovoalbúmina / CD11 b-positive cells expression in rectal mucosa from ovalbumin sensitized and challenged rabbits

El receptor MAC-1 de conejo, homólogo al CD11b humano, es una proteína presente en los macrófagos. El objetivo del presente trabajo es establecer las modificaciones cuantitativas y distributivas de células CD11bpositivas participantes en la respuesta inmune a nivel de la mucosa rectal, en un modelo animal de inmunidad mucosa. Se estudiaron conejos neocelandeses divididos en tres grupos: G1:control, G2:sensibilizado con ovoalbúmina (OVA) y G3:sensibilizado y desafiado por vía rectal con OVA. Los conejos de los grupos 2 y 3 fueron sensibilizados por vía subcutánea en dos oportunidades, con 2 ml de una suspensión de 70 µg de OVA en 30 mg de hidróxido de aluminio/ml. El desafío rectal se realizó con una solución de 50 mg OVA en 5 ml de solución salina. La prueba de anafilaxia cutánea pasiva (PCA) fue positiva en G2 y G3 a una dilución de 1/160. En el grupo sensibilizado y desafiado se observó edema mucoso parcheado, imágenes de linfangiectasias e infiltración de eosinófilos. Las células se contaron como número de células por campo de mayor ...

Impacto de nuevas metodologías en el estudio de parásitos: X. Actualidades en el estudio de la inmunología local y su aplicación en parasitosis / Impact of new metodologies in the study of parasites: X. Current findings in the study of local immunology and its application in parasitosis

La inmunología de las mucosas ha adquirido gran importancia, principalmente por la necesidad de comprender mejor la manera de estimular respuestas inmunes que prevengan enfermedades. En México, donde se reconoce la importancia de las enfermedades infecciosas que afectan mucosas (diarreas, neumonías, parasitosis) y existe un aumento preocupante de hipersensibilidades (asma, intolerancia alimentaria) no hay suficientes grupos dedicados a la investigación en esta área. El objetívo principal de los mecanismos de defensa de las mucosas es impedir la entrada del antígeno (Ag) (exclusión inmune) y evitar respuestas sistémicas indeseables (hipersensibilidad, autoinmunidad), por ejemplo contra Ags de la dieta. Una cantidad considerable de parásitos tienen como blanco o emplean las mucosas del organismo en alguna fase de su vida. A pesar de su indudable importancia, la inmunología de las mucosas en las infecciones parasitarias no ha sido estudiada en profundidad. Solo algunos estudios han abordado este tema usando animales de laboratorio y, afortunadamente, en los últimos años tienden a incrementarse. En el CINVESTAV, se estudia la inmunidad de las mucosas empleando un enfoque multidisciplinario, en proyectos que involucran parásitos como Entamoeba histolytica, Giardia lamblia y Trichinella spiralis. Tales estudios utilizan metodologías de vanguardia que se describen brevemente en este artículo.

Inmunología de la IgA y las mucosas / Immunology of IgA and of mucosas

Aunque la relevancia clínica de la IgA en las enfermedades humanas no está completamente elucidada se conoce la gran importancia que desempeña la IgA como sistema de defensa contra las infecciones, tanto para virus y bacterias, como en la autoinmunidad y la alergia. Tiene un papel muy importante en caso de infecciones del tracto respiratorio alto y bajo, como en las amigdalitis, donde se ha demostrado que su presencia es indispensable para la inmunidad local. Existen argumentos en contra de las amigdalectomías, dado que es afectada la respuesta inmune específica de las mucosas y la IgA secretoria disminuye. Además, la amigdalectomía puede agravar aún más las infecciones del tracto respiratorio superior y predisponer a una mayor sensibilización a padecer asma y otras enfermedades alérgicas. El propósito de este artículo es relatar las primeras investigaciones que permitieron el conocimiento de la inmunología de las mucosas y elucidaron la función biológica de la IgA; para analizar desde el punto de vista inmunológico, las repercusiones que tiene para el sistema inmunitario la extirpación de las amígdalas, que es un órgano linfoide secundario